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ScienceDirect
A review investigating the relationship between cannabis use and
adolescent cognitive functioning
Elena Cyrus1, Makella S Coudray2, Sandra Kiplagat2, Yandra Mariano2,
Ines Noel3, Jerome T Galea4, Dexter Hadley5, Jessy G Dévieux6 and
Eric Wagner7
Given varying state-level laws regarding cannabis use, the
objective of the review was to summarize contemporary
literature on the relationship between adolescent cognitive
function and academic performance with cannabis use.
Frequency and quantity of cannabis use were associated with
decreased functional connectivity of the brain. Earlier age at
cannabis initiation and more frequent use was associated with
poorer executive control and academic performance. Social
determinants such as minimal parental monitoring, peer use
and low social cohesion were associated with more frequent
adolescent use. Race/ethnicity and residence were other
factors influencing cannabis use. To prevent cannabis use
disorders among adolescents, interventions should aim to
prevent early initiation that can lead to chronic use in youth who
may be more at risk.
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Introduction
Cannabis, also referred to as marijuana, is one of the most
commonly used substances globally in terms of occurrence (the likelihood of an individual becoming a user)
and frequency (number of users in the population) [1]. In
terms of care and treatment, cannabis is the most commonly reported illicit psychoactive substance used among
U.S. youth [2,3]. Throughout the past 25 years, although
its decriminalization, medicalization, and legalization in
the U.S. has led to a shift in societal perceptions and usage
patterns among Americans, there is no consensus that
state-level cannabis laws and medical marijuana laws
(MML) moving towards decriminalization and legalization have necessarily increased cannabis use among adolescents [3]. The statistics reflect that across the United
States, there was no increase in average frequency of
cannabis use among adolescents post-legalization in the
US, with some data demonstrating an average 7%
decrease in monthly use among adolescents post cannabis
legalization (K. Winters, PhD, unpublished data, 2019).
Despite the apparent decrease in average cannabis use,
there are less protective trends for cannabis use disorders
(CUD), or the overuse or misuse of cannabis that can lead
to addiction [4], with at least one study suggesting an
increase in CUDs among adolescents since recreational
medical marijuana laws (RML) [5]. Individuals may be
more at risk for overusing cannabis or developing a CUD
because of increased accessibility to cannabis through
MML and legalization of recreational use in some states.
However, there has also been increase in the potency of
cannabis product over time possibly contributing to
increasing CUD prevalence in the US [6].
Risk perception, which impacts cannabis use, has varied
over time and is almost cyclical [7]. Policy changes
leading to a decrease in risk perception was at its lowest
during the Woodstock generation in the 60’s and late 70’s.
During this time, there was an increase in cannabis
consumption among middle and high school students.
The perception of cannabis harmfulness subsequently
increased in the 80’s to early 90’s, and by the mid 90’s, the
perception of cannabis harmfulness began to decrease
again [3]. A 2019 study found risk perception in adolescents was directly associated with lifetime cannabis use
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[8]. In addition to a low-risk perception among cannabis
consumers, there can also be positive beliefs about its use,
such as cannabis use increasing creativity [8].
One consideration supporting the investigation of cannabis
use in a vulnerable populations such as adolescents is
cannabis potency or D-9 tetrahydrocannabinol (THC) concentration increasing over time [6,9,10]. An examination of
cannabinoid concentration in cannabis products confiscated by the U.S. Drug Enforcement Administration
demonstrates cannabis potency tripling from 4% in
1995 to 12% in 2014 [9]. A higher THC dosage will
increase the possibility of addiction, but can also modify
the effect of cannabis on brain development, cognitive
function and mental health [9,10]. Therefore, a better
understanding of the sequelae associated with more frequent use and/or more potent cannabis exposure is crucial
information to adequately guide policy for this population.
Evidence in the extant literature regarding the long-term
effects of chronic cannabis use on adolescent neurological
functioning is limited and inconclusive. Researchers
believe there is some evidence suggesting structural
changes may result from persistent use, and these
changes might be correlated with decreased academic
performance, impairments in cognition, and increased
prevalence of addictive and mood disorders [3,10].
Understanding this public health problem among adolescents is essential to estimate the effect of frequency of use
and CUD on adolescent cognitive function. Consequently, this review aims to synthesize the current literature of limited yet varied studies on the impact of
cannabis use on cognitive function and academic performance among adolescents across the country. The review
will add to the existing research that looks at cannabis use
among adolescents for mental health outcomes [11], by
examining adolescent cognitive function, academic performance and related consequences associated with cannabis use.
The review also includes some discourse about the relevance of these findings in the context of the global Covid19 public health emergency [12]. Estimates suggest that
the COVID-19 pandemic could result in a projected
7500 additional deaths from alcohol and drug misuse
and suicide [13]. Economic change and social disconnection are the two most replicated factors associated with
suicide [14]. Given reported [12] increases in number of
legal cannabis sales and quantity purchased since the
emergence of COVID-19 pandemic, it is worth expanding the interpretation of our review findings for adolescents living in this shifting global order.

Methods
The authors searched for relevant articles in the following
databases: MEDLINE, CINAHL and PsycInfo. The
www.sciencedirect.com

search strategy included relevant keywords and MESH
terms on cannabis use, cognitive function and adolescents
(Table 1). The selected studies were published in the last
five years, from January 1, 2015 until March 5, 2020.

Study eligibility criteria
Both experimental and observational studies were
included. The study designs included case-control,
cross-sectional, cohort and randomized controlled trials.
Inclusion criteria
 Peer-reviewed articles
 Adolescents aged 12–17 years residing in the United
States without any restrictions on sex and race/ethnicity
 Articles published in the English language

Exclusion criteria
 Review studies without data or findings
 Presence of existing comorbidities as a confounder

Main outcomes
The primary outcome was cognitive function. Secondary
outcomes included academic performance, and cannabis
Table 1
Search strategy
Database

Cannabis

Adolescents

Cognitive
function

Adolescen* OR
Cognit*
teen* OR
teenager* OR
‘young people’
OR ‘school-aged
children’ OR
youth* OR
student OR
juvenil* OR ‘High
School’
(‘Cannabinoids’[Mesh] Adolescen* OR
Cogni*
OR ‘Marijuana
teen* OR
Smoking’[Mesh] OR
teenager* OR
‘Marijuana Abuse’
‘young people’
[Mesh] OR ‘Medical
OR ‘school-aged
Marijuana’[Mesh] OR
children’ OR
marijuana smoking or youth* OR
therapeutic use [Mesh] student OR
OR ‘Medical Marijuana’ juvenil* OR ‘High
[Mesh] OR
School’
‘tetrahydrocannabinol’
OR Cannabi* OR
Marijuana OR
Tetrahydrocannabinol)
(MH ‘Cannabis’) OR
(MH
(MH
(MH ‘Medical
‘Adolescence’)
‘Cognition’)
Marijuana’)
OR (MH)

PSCYINFO (Cannabi* OR
‘Marijuana Smoking’
OR ‘Medical Marijuana’
OR ‘Marijuana
Smoking’ OR
tetrahydrocannabinol)

MEDLINE

CINAHL
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use in the context of polysubstance use. The primary
exposure was cannabis use.

Search screening
The authors imported articles into Covidence Software to
initiate the search screening process based on the search
criteria identified in Table 1. Three authors (MC, SK and
YM) screened the titles and abstracts independently to
assess studies that met the inclusion criteria. The articles
were selected if there was consensus reached by two of
three authors. To minimize bias during the screening
process, a third author resolved any disagreements
between two reviewing authors. Subsequently, the
authors conducted full screening of articles to meet the
eligibility criteria using the same consensus guidelines. A
standardized data sheet form was created to perform data
extraction. The form included author, publication year,
demographic information, study setting, study population, study design, prevalence of cannabis use, study
measures of association and overall study findings. Data
was collected from multiple states with varying cannabis
policies. None of the states eligible to be included in the
review had legalized recreational use, and two of the
states (Virginia and Texas) had limited TCH/CBD programs, with the remaining states having policies short of
recreational use or comprehensive medical marijuana use
programs (see Figure 1) [15]. States with no policy or
position on cannabis use were not included in the review
because to our knowledge, there were no studies conducted in these settings.

Results
In this review, we found that cannabis use demonstrated
persistent effects on cognitive health outcomes among
adolescents and was associated with both the frequency of
use and early age of initiation of cannabis use [16–18].
The following sections provide greater details of these
associations.

Cognitive outcomes
The studies included in the review shed light on patterns
of use, and the impacts of use on cognitive function,
including academic performance. Early age of first cannabis use, frequent use and having a CUD were related to
lower cognitive function measured by several brain biomarkers discussed below. Despite this inverse relationship between cannabis use and cognitive function, one
study found some protective effects among occasional
users.
The study conducted by Becker et al. [18] determined,
through the assessment of diffusion tensor imaging
results, that cannabis users (who started using before
age 17) had decreased white matter growth in specific
regions of the brain, such as the central and parietal
regions of the right and left superior longitudinal fasciculus [18]. This altered development of white matter
Current Opinion in Psychology 2021, 38:38–48

contributed to functional impairment and decreased
cognitive function observed among cannabis users
[18]. This was shown by the diminished performance
in verbal learning and memory observed amongst cannabis users compared to non-users [18]. In addition to
these effects on verbal learning and memory, cannabis
use may also result in deleterious effects on resting
functional connectivity among adolescents with CUD
[16]. Camchong et al. [16] assessed resting functional
connectivity, intelligence quotient (IQ), and cognitive
function among 43 healthy controls and 22 treatmentseeking adolescents with CUD [16]. They determined
that adolescents with CUD showed decreased functional
connectivity, lower IQ scores, and slower cognitive
function compared to the healthy controls [16]. The
most impacted areas of the brain among adolescents
with cannabis use disorder were identified as the anterior
cingulate cortex and orbitofrontal cortex [16]. Both
Becker et al. [18] and Camchong et al. [16] explored
the effects of cannabis use on adolescent brain development through longitudinal studies and identified significant impacts on multiple areas of the brain. Camchong
et al. [16] further expanded upon the conclusions of
Becker et al. [18] by examining resting functional connectivity, which previously was not done. Both studies
presented similar findings with respect to the deleterious
effects of cannabis use on adolescent brain development
and subsequent diminished cognitive outcomes.
Cognitive outcomes such as reaction time, recall and
accuracy have been shown to be associated with cannabis
use [19]. A study conducted by Sweeney et al. [19]
evaluated working memory among individuals with substance use disorder, with cannabis being the primary
substance of abuse [19]. Adolescents were assigned to
either the experimental or control group where adolescents in the experimental group received working memory training, and those in the control did not [19]. After
adjusting for cannabis use, participants who received
training were less likely to have working memory
impairment, specifically they exhibited faster reaction
time [19].
Frequency of cannabis use and age of onset also affects
cognitive outcomes such as executive control [19,20].
The frequency of cannabis use and age of onset can lead
to deleterious effects on working memory, such as
reduced recall time and sustained attention [19,20].
Scott et al. [20] examined the relationship between
the frequency of cannabis use and age, and determined
that adolescents who were frequent users had worse
measures of executive control when compared to nonusers [20]
Age of onset of cannabis use was also significantly associated with executive control, where earlier age of cannabis
use was associated with worse performance of executive
www.sciencedirect.com
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Figure 1
Legalized

Medical and Decriminalized

Medical

Decriminalized

Fully illegal

Current Opinion in Psychology

Map of Marijuana Legality by State As of July, 2020 [41].

functioning among occasional cannabis users [20]. However in this study, compared to non-use, occasional use
was associated with better executive control, memory,
and social cognition [20].

co-occur with externalizing and attention/concentration
problems [21]. Youth who experienced academic problems in conjunction with attention/concentration problems were more likely to use cannabis [21].

Academic performance

Targeted interventions may further be necessary as literature highlights racial and ethnic differences in cannabis use [22]. For example, the study conducted by Knopf
et al. [22] determined that white youth are at the highest
risk of cannabis use during middle and high school [22].
Though the study conducted by Reboussin et al. [21]
focused only on African Americans and the Knopf et al.
[22] study included multiple races, both concluded that
marijuana use was associated with poor academic outcomes [21,22].

One relevant measure for cognitive function among adolescents is academic performance [17]. The findings
related to academic performance were an extension of
the cognitive function findings with a negative association
between cannabis use and academic performance, but
some racial/ethnic differences in terms of academic
metrics were highlighted.
One longitudinal study by Reboussin et al. [21] examined
how patterns of academic and behavioral problems in the
first grade relate to longitudinal transitions in marijuana
use from middle school to high school among African
Americans [21]. Academic difficulties were found to
www.sciencedirect.com

Earlier age of onset of cannabis use also plays an integral
role in academic performance. The study conducted by
Buchy et al. [23] examined the relationship between IQ
Current Opinion in Psychology 2021, 38:38–48
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and cannabis use among 678 youth at clinical high risk of
psychosis and 263 health controls [23]. They concluded
that there were significant differences in IQ scores among
early onset, late-onset, and naı̈ve cannabis users [23]. IQ
scores were significantly higher among late-onset cannabis users when compared to early onset and naı̈ve cannabis users [23]. The authors hypothesized that higher IQ
may lead youth at clinical high risk of psychosis to delay
the onset of their cannabis use during adolescence [23].
They further postulate that there may be an interactive
effect between cannabis use and IQ when age of onset
occurs during a sensitive development period [23]. These
findings were only observed among youth at clinically
high risk of psychosis and not among healthy controls
[23].
A prospective cohort study conducted by Meier and
colleagues among youth from an upper-middle-class community determined that persistent cannabis use throughout high school was associated with lower grade point
averages and lower scholastic aptitude test scores [24].
However, these effects were not significant after controlling for persistent alcohol and tobacco use and therefore
cannabis may not solely account for poor academic performance [24]. These findings highlight one of the considerable difficulties in substance use research and delineating the effects of the primary exposures when there is
polysubstance use and their corresponding effects [24].

Risk factors associated with polysubstance
use
There were studies providing evidence of a relationship
between social environment, cannabis use and polysubstance use [25,26,27] For example, one study was able to
predict the longitudinal risk of marijuana, tobacco and
alcohol use based on an adolescent’s social environment
[25]. As opposed to the previously mentioned Knopf et al.
[22] findings [22] which examined cannabis use among
multiple races, Musci et al. examined the risk factors
associated with African American youths only and tobacco
use and cannabis use. In the Musci et al. study, some of
the traits found in the social environment of an adolescent
who uses marijuana and/or tobacco at least moderately
were low parental monitoring and multiple friends who
engaged in substance use [25]. In the Mason and Mennis
study, general disorder in a living environment or social
disorganization in an adolescent’s neighborhood and living within an urban city environment was an indication of
behaviors leading to cannabis use [26]. This study
discussed areas in a city considered to be ‘favorite places’
that were associated with risk behaviors for cannabis use
[26].
The difference between synthetic and plant-based cannabinoid use is also a consideration when evaluating
cannabis use among contemporary adolescents. In the
2017 Ninnemann et al. study, adolescents who regularly
Current Opinion in Psychology 2021, 38:38–48

used cannabis were more likely to use synthetic cannabinoids [27]. It was also found that females and African
Americans on average use less synthetic cannabinoids
than males and people of other races and ethnicities.
On the other hand, the presence of synthetic cannabinoid
use was not indicative of subsequent marijuana use [27].

Discussion
This review adds to the preceding literature by considering the impact of cannabis use on adolescent brain development, and specifically on cognitive function and academic performance [11]. When assessing marijuana use
among adolescents, individual motivating factors and
social environmental factors appeared to be stronger
explanatory variables than state policies or governing
laws. Specifically, as previously mentioned in this review,
higher cannabis use was not always associated with medical marijuana legalization or RML in states. The first state
law allowing medical use of cannabis was enacted in
1996 [28]. Since the 1990’s, an increasing number of
states within the United States have begun to revise
policies that loosen federal restrictions on marijuana
and lean toward decriminalization of use [28].
Our study findings support the need for continuing
research to examine national trends of adolescent cannabis use as state policies and laws regarding medical and
commercial marijuana continue to evolve in the U.S.
[29] In addition to laws and ordinances, other possible
moderating factors between adolescent cannabis use and
cognitive function are settings or areas of social congregation in urban locales, less family support, less parental
monitoring, less social capital, and/or less social cohesion.
At-risk adolescents with any of these risk factors may be
heavier/more frequent users or have a CUD, with
increased odds of lower cognitive function and academic
performance in some instances.
There are differences in patterns of cannabis use by race
and ethnicity that can have differential impact on cognitive function and academic performance. For racial/ethnic
minorities, cannabis use may be more harmful on academic performance compared to adolescents who are not
racial/ethnic minorities and live in more supportive
resource-rich environments that provide advantages fostering academic development [30]. More studies are
needed to examine the reason for this racial/ethnic differences and disparities.
Finally, there has been a recent shift in social and health
paradigms because of the COVID-19 public health emergency, with the United States as one of the epicenters of
the pandemic [31]. One of the unintended consequences
of COVID-19 is its impact on mental health of the general
population. There is limited data on COVID-19 related
mental health outcomes in the US, however, data from
China, suggests that during the time of Covid-19
www.sciencedirect.com
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Author, year Study type

Sample
size

Study
location

Mean age
(years)

Cognitive performance
Becker [18]

Cohort

46

Minnesota

Camchong
[16]

–

Females =
16.5  2.7
Males = 17.6 
2.4

% Female % Male

Cannabis
prevalence

Measure of
association

30.4%non-users
30.4%cannabis
users

69.6%non-users
69.6%cannabis
users
–

–

47%

51%

–

–

65

Minneapolis
and St. Paul,
MN

Cohort

4,568

Philadelphia,
PA

17.6  1.7

31%

69%

4.97%

–

RCT

37

Baltimore,
MD

16.2

16.20%

83.80%

–

PSAT (control)- 0.31
(0.04); PSAT
(experimental) - 0.42
(0.04)

Scott [20]

Current Opinion in Psychology 2021, 38:38–48

Sweeney
[19]

Academic performance
Meier [24]

Cohort

254

Time pt 1:14/
New England,
15 Time pt
US
2:17/18

–

–

19%

b=

0.18

b=

0.13

b=

0.13

Study conclusion

Heavy cannabis use resulted
in decreased longitudinal
growth in the brain white
matter structure areas of the
- p values for all
brain and reduced
outcomes were <0.05
performance in verbal
learning and memory
compared to non-cannabis
users.
Among adolescents
diagnosed with cannabis use
disorder, there is decreased
functional connectivity in the
- p values for all
outcomes were <0.05 brain’s frontally mediated
network, lower IQ, and
slower cognitive functions
compared to non-users.
- Mild executive control
deficits were reported
among adolescents who are
frequent users (3–4 times per
week) compared to nonusers.
- Early age of initiation
- p values for all
resulted in poorer executive
outcomes were <0.05 control deficits only among
occasional users (1–2 times
per week).
- Occasional users had
better executive control,
memory and social cognition
compared to non-users.
p < 0.05
Adolescent cannabis use is
associated with working
memory impairment.

- 95% CI: -0.30, 0.05;
p = 0.006
- 95% CI: -0.24, 0.03;
p = 0.014
- 95% CI: -0.26,
0.007; p = 0.038

Persistent cannabis use (10–
19 times in the past year) was
associated with lower GPA in
12th grade, lower GPA
specifically after accounting
for 9th grade results and
lower SAT scores during
12th grade.
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Cohort

95% confidence
interval/p-value

Sample
size

Study
location

Mean age
(years)

% Female % Male

Cannabis
prevalence

Reboussin
[21]

Measure of
association

95% confidence
interval/p-value

Study conclusion

(aOR = 10.83),

- 95% CI: (2.16, 54.39)
p < 0.05
- 95% CI: (1.37–26.12)
p < 0.05

Academic problems occur in
combination with both
externalizing cannabis use
and attention/concentration
problems in African
Americans, although to a
lesser extent with
externalizing cannabis use
problems.
- White youth had a higher
likelihood of alcohol and
marijuana use compared to
other races/ethnicities.
- Nonwhite youth had worse
academic performance
compared to whites.
- Greater alcohol or
marijuana use was
associated with academic
unpreparedness and
delinquency.
- Greater marijuana use was
associated with lower
academic performance and
worse mental health
outcomes.

(aOR = 5.99)
Longitudinal 458

Baltimore,
MD

Range: 10.62–
48%
13.12

52%

60%

Longitudinal 6509

Southern CA

Range: 11.5–
17

50%

50%

–

N/A, descriptive

N/A, descriptive

CHR42%
HC-48%

CHR58%;
HC-52%

CHR early onset:
122 (18.0%)
Late onset: 227
(33.5%) Naı̈ve: 327
(48.2%)

ANCOVA: F(3,641) =
6.13.

p < 0.05

Earlier age at onset of
cannabis use may be a more
important factor for IQ than
current use or frequency

Neighborhood
disorder ([aOR] =
1.77)
City places x peer
network risk (aOR =
8.17)
–

Neighborhood
disorder ([CI] = 1.01,
3.09),
City places x peer
network risk (CI = 1.91,
35.02)
–

Neighborhood disorder and
city environment promote
peer risk behaviors which
influence cannabis use of
urban adolescents.

Knopf [22]

CHR-15.7

Buchy [23]
Prospective
cohort

941

Multi-site

Risk factors associated with polysubstance use
Mason and
Mennis
[26]
Richmond,
Longitudinal 248
VA

www.sciencedirect.com

Johnson
[29]

Cross
sectional

115379

Multi-site

HC-16.2

13–14

57%

43%

–

Grades 9–12

50%

50%

1999–2009
(44%–37%), 2009
(41%)

Despite lenient changes in
marijuana policies
throughout the US,
marijuana use among high
school students has been
declining.

44 Ken Winters
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(Continued )
Author, year Study type
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(Continued )
Author, year Study type

Sample
size

Study
location

Mean age
(years)

% Female % Male

Cannabis
prevalence

Musci, 2015

Longitudinal 556

Baltimore,
MD

11.88–17.81

46%

54%

Cross
sectional

735352

Multi-site, US Grades 9-12

–

–

Cross
sectional

715014

Multi-site, US Grades 9–12

–

–

- Gene x environment - p = 0.038
for tobacco: OR =
1.33
- Gene x environment - p = 0.046
for marijuana OR =
0.10

22.7% (MML states) - aOR = 0.93
19.8% (non-MML
- aOR = 0.98
states)

Johnson
[42]

–

- 95% CI: 0.87-0.97; p
< 0.05

- 0.93

aOR = 0.60

- 95% CI: 0.87-0.99; p
< 0.05
- 95% CI: (0.92-0.97);
p < 0.001
- 95% CI: (0.94, 0.99; p
< 0.05
- p = .005

aOR = 0.50

- p = .046

- 0.96

Current Opinion in Psychology 2021, 38:38–48

Longitudinal 964

Galveston, TX Grades 9–12

56%

44%

- 95% CI: 0.86–0.89
- 95% CI: 0.96–0.998

- 0.92

- 0.94

Ninnemann
[27]

95% confidence
interval/p-value

–

Study conclusion
- Taking the interaction into
account, most users of
marijuana and tobacco were
shown to have social
environments with low
parent monitoring and
friends that used substances
(not limited to marijuana and
tobacco)
Medical marijuana law
enactment and its inclusion
of more liberalized provisions
were associated with slightly
lowered odds of past 30-day
marijuana use.
- Medical Marijuana laws
enactment was associated
with decreased odds of past
30 day alcohol use, past
30 day alcohol and marijuana
use.
- States with less restrictive
medical marijuana laws had
decreased odds of past
30 day alcohol and marijuana
use.
- Plant-based marijuana use
was predictive of
subsequent synthetic
cannabinoid use, but
synthetic cannabinoid use
was not predictive of later
marijuana use.
- Females and African
Americans were less likely to
use synthetic cannabinoids
compared to males, and
other races respectively.

A review of cannabis use and adolescent functioning and performance Cyrus et al. 45

Johnson
[43]

–

Measure of
association

46 Ken Winters

pandemic, mitigation policies, including social distancing
and social isolation led to increased levels of anxiety and
depression in the general population [32]. An increase in
these mental health conditions may have an impact on
substance use initiation, frequency and quantity of use,
and use related problems [33,34], particularly among
adolescents who may be experiencing a number of challenging mental health conditions that are present during
this time [11].
Study limitations

The overall finding was that harmful effects are more
likely associated with more frequent or heavier use, but
there was no structured consistent guidance or definition
of a ‘more frequent’ or ‘heavier’ user.
The lack of standardized measures for cannabis use did
not allow for a deeper analysis or comparison among
studies and prohibited any type of data pooling or analysis
[35]. While there are number of self-report validated
scales capturing information on patterns and modalities
of cannabis use [36], there are limited complementary
biomarker tests providing information beyond substance
presence, to help with understanding cannabis toxicity
levels for adolescents that would be considered harmful
use. Besides varying definitions for ‘heavy’, ‘moderate’ or
‘light’ use, there is also minimal descriptions on THC
concentration or potency. Relatedly, there is no concrete
guidance about biochemical differences between synthetic and plant-based marijuana use on adolescents’
cognitive function or mental health. Finally, there were
limited longitudinal studies to understand temporal patterns and relationships.

Conclusion
This review found adolescent cannabis use was associated
with poorer outcomes on key markers and milestones for
adolescent cognitive function. The study findings will be
of interest to parents, educators and the scientific community who serve and work with adolescent populations.
It should be noted that there are still significant gaps to be
addressed, including studies using systematic methods
are needed that assess outcomes using standardized measures for dosage, THC exposure and frequency of use,
and, longitudinal studies. Additionally, cannabis studies
should be conducted in the context of individual’s community and social environment.
Recent global health events have catapulted the US along
with other countries into an unprecedented phase of
physical distancing and isolation in response to the
Covid-19 epidemic [37–39]. There may be a simultaneous increase in prevalence of depression, anxiety, stress
and loneliness in the general population because of these
distancing measures [40]. During and immediately after
the social distancing phase, it is anticipated that substance
use, including cannabis use, will be used as a coping
Current Opinion in Psychology 2021, 38:38–48

mechanism and increase among people who experience
some of these mental health conditions. This is relevant
for adolescents who were already engaging in cannabis
use or at-risk of use, as they may also increase their use
while adapting to the Covid-19 crisis.
Not only can physical distancing have a direct impact on
cannabis use and mental health, but also the sudden and
unexpected change of environment and social norms can
potentially propagate other negative outcomes or unintended consequences of the pandemic in all segments of
the population. Therefore, to prevent the disruption of
successful long-term adolescent trajectories, more
research is urgently needed regarding the deleterious
health effects of more frequent cannabis use or CUD
during the COVID-19 pandemic on cognitive function,
academic performance, mental health and resilience.
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10. Lubman DI, Cheetham A, Yücel M: Cannabis and adolescent
brain development. Pharmacol Ther 2015:1-16 http://dx.doi.org/
10.1016/j.pharmthera.2014.11.009.
11. Gobbi G, Atkin T, Zytynski T et al.: Association of cannabis use in
 adolescence and risk of depression, anxiety, and suicidality in
young adulthood: a systematic review and meta-analysis.
JAMA Psychiatry 2019:426-434 http://dx.doi.org/10.1001/
jamapsychiatry.2018.4500.
The authors conducted a systematic review and meta-analysis which
concluded that adolescent cannabis use was signi1cantly increased the
likelihood of depression, suicidal ideation and suicidal attempt.
12. Hansen C: Coronavirus Pandemic Boosts Marijuana Sales While
Many Businesses Struggle. 2020.
13. Well Being Trust: The COVID Pandemic Could Lead to 75,000
Additional Deaths from Alcohol and Drug Misuse and Suicide. Well
Being Trust & The Robert Graham Center Analysis.
14. Act now to get ahead of a mental health crisis, specialists
advise U.S.Yuki Noguchi: The Coronavirus Crisis.
15. VanDolah HJ, Bauer BA, Mauck KF: Clinicians’ guide to
cannabidiol and hemp oils. Mayo Clin Proc 2019, 94:1840-1851
http://dx.doi.org/10.1016/j.mayocp.2019.01.003.
16. Camchong J, Lim KO, Kumra S: Adverse effects of cannabis on
adolescent brain development: a longitudinal study. Cereb
Cortex 2017, 27:1922-1930 http://dx.doi.org/10.1093/cercor/
bhw015.
17. Scott JC, Slomiak ST, Jones JD, Rosen AFG, Moore TM, Gur RC:
Association of cannabis with cognitive functioning in
adolescents and young adults. JAMA Psychiatry 2018, 75:585
http://dx.doi.org/10.1001/jamapsychiatry.2018.0335.
18. Becker MP, Collins PF, Lim KO, Muetzel RL, Luciana M:
Longitudinal changes in white matter microstructure after
heavy cannabis use. Dev Cogn Neurosci 2015, 16:23-35 http://
dx.doi.org/10.1016/j.dcn.2015.10.004.
19. Sweeney MM, Rass O, DiClemente C et al.: Working memory
training for adolescents with cannabis use disorders: a
www.sciencedirect.com

22. Knopf A: Nonwhite youth have more academic problems on
alcohol and marijuana than white youth. Brown Univ Child
Adolesc Behav Lett 2016, 32:4-5.
23. Buchy L, Seidman LJ, Cadenhead KS et al.: Evaluating the
relationship between cannabis use and IQ in youth and young
adults at clinical high risk of psychosis. Psychiatry Res 2015,
230:878-884 http://dx.doi.org/10.1016/j.psychres.2015.11.033.
24. Meier MH, Hill ML, Small PJ, Luthar SS: Associations of
adolescent cannabis use with academic performance and
mental health: a longitudinal study of upper middle class
youth. Drug Alcohol Depend 2015:207-212 http://dx.doi.org/
10.1016/j.drugalcdep.2015.09.010.
25. Musci RJ, Uhl G, Maher B, Ialongo NS: Testing gene 
environment moderation of tobacco and marijuana use
trajectories in adolescence and young adulthood. J Consult
Clin Psychol 2015:866-874 http://dx.doi.org/10.1037/a0039537.
26. Mason MJ, Mennis J: Young urban adolescents’ activity
 spaces, close peers, and the risk of cannabis use: a socialspatial longitudinal analysis. Subst Use Misuse 2018:2032-2042
http://dx.doi.org/10.1080/10826084.2018.1452260.
The authors conducted a longitudinal social-spatial analysis which concluded that increased cannabis use was associated with preference for
city places and adolescents with risky peer networks.
27. Ninnemann AL, Choi HJ, Stuart GL, Temple JR: Longitudinal
predictors of synthetic cannabinoid use in adolescents.
Pediatrics 2017:e20163009 http://dx.doi.org/10.1542/peds.20163009.
28. Mead A: The legal status of cannabis (marijuana) and
cannabidiol (CBD) under U.S. Law. Epilepsy Behav 2017:288291 http://dx.doi.org/10.1016/j.yebeh.2016.11.021.
29. Johnson RM, Fairman B, Gilreath T et al.: Past 15-year trends in
 adolescent marijuana use: differences by race/ethnicity and
sex. Drug Alcohol Depend 2015:8-15 http://dx.doi.org/10.1016/j.
drugalcdep.2015.08.025.
This study analysed data from the National Youth Risk Behavior Survey
and concluded that Despite considerable changes in state marijuana
policies over the past 15 years, marijuana use among high school
students has largely declined. Their 1ndings also illustrated that the
prevalence of past 30 day marijuana use from 19992013 was lowest
among Asians and highest among American Indians/Alaskan Natives.
The differences between male-female marijuana use decreased over
time.
30. Card D, Rothstein J: Racial segregation and the black-white
test score gap. J Public Econ 2007:2158-2184 http://dx.doi.org/
10.1016/j.jpubeco.2007.03.006.
31. Fauci Anthony S, Lane C, Redfield R: Covid-19 — navigating the
uncharted. N Engl J Med 2020, 382:1268-1269 http://dx.doi.org/
10.1056/NEJMe2002387.
32. Rajkumar RP: COVID-19 and mental health: a review of the
existing literature. Asian J Psychiatry 2020:102066 http://dx.doi.
org/10.1016/j.ajp.2020.102066.
33. Corroon JM, Mischley LK, Sexton M: Cannabis as a substitute
for prescription drugs - a cross-sectional study. J Pain Res
2017:989-998 http://dx.doi.org/10.2147/JPR.S134330.
34. Kosiba JD, Maisto SA, Ditre JW: Patient-reported use of medical
cannabis for pain, anxiety, and depression symptoms:
Current Opinion in Psychology 2021, 38:38–48

48 Ken Winters

systematic review and meta-analysis. Soc Sci Med 2019:181192 http://dx.doi.org/10.1016/j.socscimed.2019.06.005.
35. Griffith LE, Van Den Heuvel E, Fortier I et al.: Statistical
approaches to harmonize data on cognitive measures in
systematic reviews are rarely reported. J Clin Epidemiol
2015:154-162 http://dx.doi.org/10.1016/j.jclinepi.2014.09.003.
36. Piontek D, Kraus L, Klempova D: Short scales to assess
cannabis-related problems: a review of psychometric
properties. Subst Abuse Treat Prev Policy 2008:25 http://dx.doi.
org/10.1186/1747-597X-3-25.
37. Eubank S, Eckstrand I, Lewis B, Venkatramanan S, Marathe M,
Barrett CL, Commentary on Ferguson et al.: Impact of nonpharmaceutical interventions (NPIs) to reduce COVID-19
mortality and healthcare demand. Bull Math Biol 2020:1-7 http://
dx.doi.org/10.1007/s11538-020-00726-x.
38. Ferguson NM, Laydon D, Nedjati-Gilani G et al.: Impact of Nonpharmaceutical Interventions (NPIs) to Reduce COVID-19 Mortality
and Healthcare Demand. ImperialAcUk; 2020 http://dx.doi.org/
10.25561/77482.

Current Opinion in Psychology 2021, 38:38–48

39. Gt Walker P, Whittaker C, Watson O et al.: The global impact of
COVID-19 and strategies for mitigation and suppression. Imp
Coll COVID-19 Response Team 2020:413-422.
40. Torales J, O’Higgins M, Castaldelli-Maia JM, Ventriglio A: The
outbreak of COVID-19 coronavirus and its impact on global
mental health. Int J Soc Psychiatry 2020:317-320 http://dx.doi.
org/10.1177/0020764020915212.
41. DISA Global Solutions: Map of Marijuana Legality by State. https://
disa.com/map-of-marijuana-legality-by-state.
42. Johnson JK, Johnson RM, Hodgkin D, Jones AA, Matteucci AM,
Harris SK: Heterogeneity of state medical marijuana laws and
adolescent recent use of alcohol and marijuana: Analysis of
45 states, 1991-2011. Subst Abuse 2018, 39(2):247-254.
43. Johnson J, Hodgkin D, Harris SK: The design of medical
marijuana laws and adolescent use and heavy use of
marijuana: Analysis of 45 states from 1991 to 2011. Drug
Alcohol Depend 2017, 170:1-8.

www.sciencedirect.com

